Qualitative and quantitative changes in expression of CD44 and its isoforms have been demonstrated for several tumor models revealing prognostic significance for neuroblastoma[18], breast cancer[13], squamous cell esophageal cancer[19], osteosarcoma[20], and gastric cancer[21]. Here, CD44 is linked to esophageal squamous cell carcinoma.